Vaxcyte, Inc. — Director's Dealing 2022

May 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2022-05-20

Reporting Person: Fairman Jeff (VP, Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-20	Common Stock	S	4112	$25.50	Disposed	321227	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17662	Direct
Common Stock	50000	Indirect

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2: Includes 1,033 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.